Addendum to Notice of General Meeting
Released
Released
Announcement PDF
All Registry communications to:
Automic
Group GPO
Box 5193
Sydney NSW 2001
Telephone (free call within Australia): 1300 288 664
ASX/AIM Code: CLA
16 April 2026
Addendum to Notice of Meeting
Dear Shareholder,
Celsius Resources limited ACN 009 162 949 (ASX/AIM: CLA or “the Company”), advises that a General Meeting will be held in
person at Level 5, 191 St Georges Terrace, Perth, Western Australia 6000 on Thursday, 30 April 2026 at 3:00pm AWST (Meeting).
Notice of Meeting
The Company has amended the Notice of Meeting and Explanatory Memorandum (Notice) announced to ASX on 31 March 2026
to revise Resolutions 2 and 3 in the Notice (Revised Resolutions) and to include an additional resolution to approve the issue of
Consideration Shares to Managing Director Bardin Davis (Additional Resolution). The Revised Resolutions and Additional
Resolution, along with the related Explanatory Memorandum disclosure is contained in the Addendum to the Notice of General
Meeting (Addendum), together with a Replacement Proxy Form, announced to ASX on 16 April 2026. The Addendum for the
Meeting is available online and can be viewed and downloaded by shareholders of the Company (Shareholders) from the
Company’s website at https://celsiusresources.com/announcements or the Company's ASX market announcements platform at
www.asx.com.au (ASX: CLA).
In accordance with sections 110C-110K of the Corporations Act 2001 (Cth) (as inserted by the Treasury Laws Amendment (2021
Measures No.1) Act 2021 (Cth), Shareholders will not be sent a hard copy of the Notice or Proxy Form unless Shareholders have
already notified the Company that they wish to receive documents such as the Notice and Proxy Form in hard copy.
Voting by Proxy
For further information on the online proxy lodgment process, or if you require a hard copy Proxy Form, please contact the
Company’s Share Registry, Automic Registry Services (Automic), at hello@automicgroup.com.au or via phone on 1300 288 664
(within Australia) or +61 2 9698 5414 (overseas).
Online
scan the QR code
below using your
smartphone
Lodge your Proxy vote online at https://investor.automic.com.au/#/loginsah by following the
instructions:
1. Login to the Automic website using the holding details as shown on your holding statement.
2. Click on ‘Meetings’ – ‘Vote’.
To use the online lodgment facility, Shareholders will need their holder number (Securityholder
Reference Number (SRN) or Holder Identification Number (HIN)) as shown at the top of your holding
statement.
Shareholder queries in relation to the Meeting
Shareholders can contact the Company Secretary with any questions prior to the meeting via email at
info@celsiusresources.com.au.
Copies of all Meeting related material including the Notice and the Addendum, are available to download from the Company’s
website and the Company's ASX market announcements platform. In the event it is necessary or appropriate for the Company to
make alternative arrangements for the Meeting, information will be provided to Shareholders via the ASX and the Company’s
website.
Authorised for ASX release by Chairman, Peter Hume.
Page 1
Celsius Resources Limited
ACN 009 162 949
(Company)
Addendum to Notice of General Meeting
Celsius Resources Limited (ACN 009 162 949) (Company) hereby provides this addendum (Addendum)
to the Notice of General Meeting dated 31 March 2026 (Notice).
The Meeting will be held at Level 5, 191 St Georges Terrace, Perth WA 6000 on Thursday, 30 April 2026
at 3.00pm (AWST).
Defined terms in the Notice have the same meaning in this Addendum unless otherwise stated.
This Addendum is supplemental to the original Notice and should be read in conjunction with the Notice.
Save for the amendments set out below, the Notice remains unchanged.
The numbering used in this Addendum is a continuation of the numbering used in the Notice.
This Addendum should be read in its entirety. If Shareholders are in doubt as to how they should vote
they should seek advice from their suitably qualified professional advisors prior to voting. Should you wish
to discuss the matters set out in this Addendum, please do not hesitate to contact the Company Secretary
by telephone on +61 (8) 9324 4516.
Shareholders are urged to vote by lodging the replacement Proxy Form.
Amendments
By this Addendum:
(a) existing Resolution 2 is deleted from the Notice and replaced with a new Resolution 2 detailed
below;
(b) existing Resolution 3 is deleted from the Notice and replaced with a new Resolution 3 detailed
below;
(c) the voting exclusion for Resolution 2 is deleted from the Notice and replaced with a new
exclusion detailed below;
(d) the voting exclusion for Resolution 3 is deleted from the Notice and replaced with a new
exclusion detailed below;
(e) existing Section 3.1 to the Explanatory Memorandum is deleted and replaced with a new
Section 3.1 detailed below;
(f) existing Section 4 the Explanatory Memorandum is deleted and replaced with a new Section
4 detailed below;
(g) existing Section 5 the Explanatory Memorandum is deleted and replaced with a new Section
5 detailed below;
(h) a new Resolution 7 detailed below is added to the Notice and will be considered at the
Meeting;
(i) a new voting exclusion for Resolution 7 is added to the Notice;
(j) a new voting prohibition for Resolution 7 is added to the Notice;
Page 2
(k) a new Section 9 is added to the Explanatory Memorandum detailed below;
(l) amendments to Schedule 1 are added to the Explanatory Memorandum; and
(m) a new Schedule 4 is added to the Notice.
Replacement Proxy Form
A replacement Proxy Form (Replacement Proxy Form) has been made available with this Addendum,
which replaces the Proxy Form that was attached to the Notice (Original Proxy Form).
Shareholders are advised to follow the below instructions if you have already submitted a proxy vote:
• if you wish to change your vote on Resolution 2 or Resolution 3, you can submit your proxy in
accordance with the instructions on the Replacement Proxy Form;
• if Shareholders wish to have their votes counted by proxy in respect of Resolution 7, Shareholders
must use the Replacement Proxy Form to vote on ALL Resolutions;
• if you have already voted and do not wish to change your vote on Resolution 2 or Resolution 3 or
vote on additional Resolution 7, you do not need to take any action, as the proxy you previously
submitted remains valid.
The Company may accept Proxy Forms dispatched with the original Notice received from Shareholders
in the event that a Replacement Proxy Form is not provided by the relevant Shareholder.
BY ORDER OF THE BOARD
Peter Hume
Chairman
Celsius Resources Limited
Dated: 16 April 2026
Page 3
AGENDA
The Agenda of the Notice is amended by including the following new Resolution 2 and Resolution 3:
Resolution 2 – Approval to issue Placement Options
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes, Shareholders
approve the issue of up to 231,625,000 Placement Options on the terms and conditions in the
Explanatory Memorandum.’
Important Note: The Securities the subject of this Resolution are expressed in this Notice and the
Explanatory Memorandum on a pre-Consolidation basis.
Resolution 3 – Approval to issue Director Placement Securities
To consider and, if thought fit, to pass with or without amendment, each as a separate ordinary
resolution the following:
‘That, pursuant to and in accordance with Listing Rule 10.11 and for all other purposes, Shareholders
approve the issue of up to 2,625,000 Director Placement Securities as follows:
(a) up to 750,000 Director Placement Securities to Neil Grimes; and
(b) up to 1,875,000 Director Placement Securities to Bardin Davis,
(or their respective nominee(s)), on the terms and conditions in the Explanatory Memorandum.’
Important Note: The Securities the subject of this Resolution are expressed in this Notice and the
Explanatory Memorandum on a pre-Consolidation basis.
Resolution 7 – Approval to issue Consideration Shares to Bardin Davis
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 10.14 and for all other purposes, Shareholders
approve the issue of the Consideration Shares to Bardin Davis (or his nominee/s) under the Plan, on
the terms and conditions in the Explanatory Memorandum.’
Important Note: The Securities the subject of this Resolution are expressed in this Notice and the
Explanatory Memorandum on a pre-Consolidation basis.
Voting exclusions
Pursuant to the Listing Rules, the Company will disregard any votes cast in favour of
(a) Resolution 2: by or on behalf of any person who is expected to participate in, or who will
obtain a material benefit as a result of, the proposed issue of the Placement Options (except
a benefit solely by reason of being a Shareholder), or any of their respective associates.
(b) Resolution 3(a): by or on behalf of Neil Grimes (or his nominee/s), and any other person who
will obtain a material benefit as a result of the issue of these Director Placement Securities
(except a benefit solely by reason of being a Shareholder), or any of their respective
associates.
Page 4
(c) Resolution 3(b): by or on behalf of Bardin Davis (or his nominee/s), and any other person
who will obtain a material benefit as a result of the issue of these Director Placement
Securities (except a benefit solely by reason of being a Shareholder), or any of their
respective associates.
(d) Resolution 7: by or on behalf of Bardin Davis (or their nominee/s), and any other person
referred to in Listing Rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the Plan,
or any of their respective associates.
The above voting exclusions do not apply to a vote cast in favour of the relevant Resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with directions given to the proxy or attorney to vote on the Resolution in that way;
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides;
or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not
excluded from voting, and is not an associate of a person excluded from voting, on the
Resolution; and
(ii) the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Voting prohibition
Resolution 7: In accordance with section 250BD of the Corporations Act, a person appointed as a
proxy must not vote on the basis of that appointment on this Resolution if:
(a) the proxy is either a member of the Key Management Personnel or a Closely Related Party of
such member; and
(b) the appointment does not specify the way the proxy is to vote on this Resolution.
However, the above prohibition does not apply if:
(a) the proxy is the Chair; and
(b) the appointment expressly authorises the Chair to exercise the proxy even though this
Resolution is connected directly or indirectly with remuneration of a member of the Key
Management Personnel.
Page 5
EXPLANATORY MEMORANDUM
Section 3.1 in the Notice is deleted and replaced as follows:
3.1 Background
On 23 February 2026, the Company announced that it had received firm commitments for a
$9.3 million (before costs) placement via the issue of up to 465,000,000 Shares (Placement
Shares) at an issue price of $0.02 per Placement Share (Placement), with one free attaching
option for every two Placement Shares subscribed for and issued in the Placement, expiring 3
years from the date of issue with an exercise price of $0.035 per option (Placement Options).
Evolution Capital Pty Ltd (Lead Manager) acted as the sole lead manager and sole bookrunner
to the Placement. A summary of the Lead Manager Mandate is set out in Section 6.2.
The Placement is comprised of the following tranches:
(a) Tranche 1: the issue of 463,250,000 Placement Shares to unrelated Placement
participants (Tranche 1 Placement Shares), which were issued on 27 February 2026
without prior Shareholder approval under Listing Rule 7.1 (the subject of Resolution 1).
(b) Tranche 2: subject to and conditional on the prior receipt of Shareholder approval, the
issue of up to 231,625,000 Placement Options to unrelated Placement participants (the
subject of Resolution 2); and
(c) Tranche 3: subject to and conditional on the prior receipt of Shareholder approval,
the issue of up to 1,750,000 Placement Shares (Director Placement Shares) and up
to 875,000 Placement Options to Directors Neil Grimes and Bardin Davis (Director
Placement Options) (collectively, the Director Placement Securities), in the
following proportions:
(i) up to 500,000 Director Placement Shares and 250,000 Director Placement
Options to Neil Grimes (or his nominee/s) (the subject of Resolution 3(a));
and
(ii) up to 1,250,000 Director Placement Shares and 625,000 Director Placement
Options to Bardin Davis (or his nominee/s) (the subject of Resolution 3(b)).
In addition, the Company has agreed to issue up to 58,125,000 Options to the Lead Manager
(or its nominee/s) as partial consideration for the provision of lead managerial and bookrunner
services in connection with the Placement (Broker Options) (the subject of Resolution 4).
Resolution 1 seeks the approval of Shareholders pursuant to Listing Rule 7.4 to ratify the prior
issue of the Tranche 1 Placement Shares.
The Company confirms that Listing Rule 7.1 was not breached at the time the Tranche 1
Placement Shares were agreed to be issued.
Page 6
The following new Sections 4 and 5 are added to the Explanatory Memorandum of the Notice in
respect of Resolution 2 and Resolution 3 as follows:
4. Resolution 2 – Approval to issue Placement Options
The background to the Placement, including the proposed issue of the Placement Options, is
set out in Section 3.1.
Resolution 2 seeks the approval of Shareholders pursuant to Listing Rule 7.1 to approve the
issue of up to 231,625,000 Placement Options.
4.2 Listing Rule 7.1
A summary of Listing Rule 7.1 is set out in Section 3.2.
The effect of Shareholders passing Resolution 2 will be to allow the Company to retain the
flexibility to issue Equity Securities in the future up to the 15% placement capacity set out in
Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
If Resolution 2 is passed, the Company will be able to proceed with the issue of the Placement
Options. In addition, the issue of the Placement Options will be excluded from the calculation
of the number of Equity Securities that the Company can issue without Shareholder approval
under Listing Rule 7.1.
If Resolution 2 is not passed, the Company will not be able to proceed with the issue of the
Placement Options.
4.3 Specific information required by Listing Rule 7.3
Pursuant to and in accordance with Listing Rule 7.3, the following information is provided in
relation to the proposed issue of the Placement Options:
(a) The Placement Options will be issued to professional and sophisticated investors who
subscribed for and were issued Tranche 1 Placement Shares, none of whom are a
related party of the Company or a Material Investor. The Placement participants were
identified through a bookbuild process, which involved the Company and the Lead
Manager seeking expressions of interest to participate in the Placement from new and
existing contacts of the Company and Lead Manager.
(b) A maximum of 231,625,000 Placement Options will be issued.
(c) The Placement Options will be exercisable at $0.035 each and expire 3 years from
the date of issue and will otherwise be on the terms and conditions in Schedule 2.
(d) The Placement Options will be issued no later than 3 months after the date of the
Meeting.
(e) As the Placement Options are free attaching to the Placement Shares, the Company
will not receive any cash consideration for the issue of the Placement Options.
(f) Refer to Section 3.3(e) for a summary of the intended use of funds raised from the
Placement.
(g) There are no other material terms to the proposed issue of the Placement Options.
Page 7
(h) A voting exclusion statement is included in the Notice.
4.4 Additional information
Resolution 2 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 2.
5. Resolution 3 – Approval to issue Director Placement Securities
5.1 General
The background to the Placement, including the proposed issue of the Director Placement
Securities, is set out in Section 3.1.
The Company has received firm commitments from Directors Neil Grimes and Bardin Davis
(together, the Participating Directors) of up to $35,000 (before costs) on the same terms as
other unrelated Placement participants, subject to Shareholder approval, being the issue of up
to 1,750,000 Director Placement Shares and 875,000 Director Placement Options, in the
following proportions:
Participating
Director
Amount committed
to the Placement
Director Placement
Shares
Director Placement
Options
Neil Grimes $10,000 500,000 250,000
Bardin Davis $25,000 1,250,000 625,000
Total $35,000 1,750,000 875,000
Resolution 3(a) and Resolution 3(b) respectively seek the approval of Shareholders pursuant
to Listing Rule 10.11 for the issue of the Director Placement Securities to Mr Grimes and Mr
Davis (or their respective nominee/s).
5.2 Listing Rule 10.11
Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a
listed company must not issue or agree to issue Equity Securities to any of the following persons
without the approval of Shareholders:
(a) a related party (Listing Rule 10.11.1);
(b) a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (30%+) in the company (Listing Rule 10.11.2);
(c) a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (10%+) in the company and who has nominated a director to the
board of the company pursuant to a relevant agreement which gives them a right or
expectation to do so (Listing Rule 10.11.3);
(d) an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3 (Listing
Rule 10.11.4); or
(e) a person whose relationship with the company or a person referred to in Listing
Rules 10.11.1 or 10.11.4 is such that, in ASX’s opinion, the issue or agreement should
be approved by its shareholders (Listing Rule 10.11.5).
Page 8
The Participating Directors are each a related party of the Company by virtue of being Directors
of the Company.
Shareholder approval pursuant to Listing Rule 10.11 is therefore required unless an exception
applies. It is the view of the Board (with the Participating Directors abstaining) that the
exceptions set out in Listing Rule 10.12 do not apply in the current circumstances.
Approval pursuant to Listing Rule 7.1 is not required for the issue of the Director Placement
Securities as approval is being obtained under Listing Rule 10.11. Accordingly, the issue of
these Director Placement Securities to the Participating Directors (or their respective
nominee/s) will not be included in the Company’s 15% placement capacity pursuant to Listing
Rule 7.1.
The effect of Shareholders passing Resolution 3(a) will be to allow the Company to issue those
Director Placement Securities to Mr Grimes (or his nominee/s), raising a further $10,000 (before
costs) under the Placement.
If Resolution 3(a) is not passed, the Company will not be able to proceed with the issue of those
Director Placement Securities and will not raise the additional $10,000 (before costs) committed
by Mr Grimes.
The effect of Shareholders passing Resolution 3(b) will be to allow the Company to issue the
Director Placement Securities to Mr Davis (or his nominee/s), raising a further $25,000 (before
costs) under the Placement.
If Resolution 3(b) is not passed, the Company will not be able to proceed with the issue of those
Director Placement Securities and will not raise the additional $25,000 (before costs) committed
by Mr Davis.
Resolution 3(a) and Resolution 3(b) are each separate Resolutions and are not conditional on
each other and Shareholders may approve one of these Resolutions in which case, the Director
Placement Securities the subject of the relevant Resolution will be issued, even though
Shareholders have not approved both of these Resolutions.
5.3 Specific information required by Listing Rule 10.13
Pursuant to and in accordance with Listing Rule 10.13, the following information is provided in
relation to the proposed issue of the Director Placement Securities:
(a) The Director Placement Securities will be issued to the Participating Directors (and/or
their respective nominee/s) in the proportions set out in Section 5.1 above.
(b) The Participating Directors each fall into the category stipulated by Listing Rule 10.11.1.
In the event the Director Placement Securities are issued to a nominee of a
Participating Director, that nominee will fall into the category stipulated by Listing Rule
10.11.4.
(c) A maximum of 1,750,000 Director Placement Shares and 875,000 Director Placement
Options will be issued to the Participating Directors (and/or their respective nominee/s)
in the proportions set out in Section 5.1 above.
(d) The Director Placement Shares will be fully paid and rank equally in all respects with
the Company’s existing Shares on issue. The Director Placement Options will be
exercisable at $0.035 each and expire 3 years from the date of issue and will
otherwise be on the terms and conditions in Schedule 2.
(e) The Director Placement Securities will be issued no later than 1 month after the date of
Page 9
the Meeting.
(f) The Director Placement Shares will be issued at a price of $0.02 each, being the same
price as those Placement Shares issued to non-related party participants in the
Placement. As the Director Placement Options are free attaching to the Director
Placement Shares, the Company will not receive any cash consideration for the issue
of the Director Placement Options.
(g) Refer to Section 3.3(e) for a summary of the intended use of funds raised from the
Placement.
(h) The proposed issue of the Director Placement Securities is not intended to remunerate
or incentivise the Participating Directors.
(i) There are no other material terms to the proposed issue of the Director Placement
Securities.
(j) A voting exclusion statement is included in the Notice.
5.4 Chapter 2E of the Corporations Act
In accordance with Chapter 2E of the Corporations Act, in order to give a financial benefit to a
related party, the Company must:
(a) obtain Shareholder approval in the manner set out in sections 217 to 227 of the
Corporations Act;
(b) give the benefit within 15 months following such approval,
unless the giving of the financial benefit falls within an exception set out in sections 210 to 216
of the Corporations Act.
The proposed issue of the Director Placement Securities constitutes giving a financial benefit
to a related party of the Company.
The Board (with the Participating Directors abstaining) considers that Shareholder approval
pursuant to Chapter 2E of the Corporations Act is not required in respect of the issue of the
Director Placement Securities because the Director Placement Securities will be issued on the
same terms as those Securities issued to non-related party participants in the Placement and
as such the giving of the financial benefit is on arm’s length terms.
5.5 Additional information
Resolution 3(a) and Resolution 3(b) are each separate ordinary resolutions.
The Board (with the Participating Directors abstaining due to their personal interest in the
outcome of these Resolutions) recommends that Shareholders vote in favour of Resolution 3(a)
and Resolution 3(b).
Page 10
9. Resolution 7 – Approval to issue Consideration Shares to Bardin Davis
9.1 General
On 9 January 2026, the Company announced that it had engaged Mr Bardin Davis as a
consultant to the Board on matters of strategy, financing and project development (Services).
Pursuant to that engagement, the Company agreed to pay 50% of the fees for services provided
to the Company in Shares pursuant to the Plan (Consideration Shares).
A summary of the material terms of the engagement of Mr Bardin pursuant to that consultancy
agreement is in Section 9.2 below (Consultancy Agreement).
The Company is proposing, subject to obtaining Shareholder approval, to issue Consideration
Shares pursuant to the Plan to Mr Bardin (or his nominee/s) for the provision of Services
provided to the Company during the period January 2026 to March 2026 in the amount of
A$7,615.
Resolution 7 seeks the approval of Shareholders pursuant to Listing Rule 10.14 to approve
the issue of the Consideration Shares.
9.2 Consultancy Agreement
The key terms of the Consultancy Agreement are as follows:
(a) Term: 3 months, unless extended.
(b) Consideration: A$200 per hour (capped at $1,400 per day). 50% is payable in cash
and 50% is payable in Shares based on the 5-day volume weighted average price of
the Company’s shares prior to the date of issue.
(c) Scope of services: Mr Bardin was engaged to provide certain consulting services,
including: strategic repositioning of the Company; equity market positioning and
investor relations; equity capital raisings; project funding; and; strategic partnering.
The Consultancy Agreement contains various other provisions which are considered
customary for an agreement of its nature.
9.3 Listing Rule 10.14
Listing Rule 10.14 provides that an entity must not permit any of the following persons to
acquire Equity Securities under an employee incentive scheme without the approval of its
Shareholders:
(a) a director of the entity (Listing Rule 10.14.1);
(b) an associate of a person referred to in Listing Rule 10.14.1 (Listing Rule 10.14.2); and
(c) a person whose relationship with the entity or a person referred to in Listing Rule
10.14.1 or 10.14.2 is such that, in ASX’s opinion, the acquisition should be approved
by security holders.
Approval pursuant to Listing Rule 7.1 is not required for the issue of the Consideration Shares
as approval is being obtained under Listing Rule 10.14. Accordingly, the issue of the
Consideration Shares to Mr Davis (or his nominee/s) will not be included in the Company’s
15% annual placement capacity in Listing Rule 7.1.
Page 11
The effect of Shareholders passing Resolution 7 will be to allow the Company to issue the
Consideration Shares to Mr Davis (or his nominee/s).
9.4 Specific information required by Listing Rule 10.15
Pursuant to and in accordance with Listing Rule 10.15, the following information is provided in
relation to the proposed issue of the Consideration Shares:
(a) The Consideration Shares will be issued under the Plan to Mr Davis (or his
nominee/s).
(b) Mr Davis falls into the category stipulated by Listing Rule 10.14.1 by virtue of being a
Director of the Company. In the event the Consideration Shares are issued to a
nominee of Mr Davis, that person will fall into the category stipulated by Listing Rule
10.14.2.
(c) The number of Consideration Shares to be issued is not fixed or subject to any floor
price. The number of Consideration Shares to be issued will be based on the 5-day
volume weighted average price of the Company’s shares prior to the date of issue.
By way of illustration only, the following table shows the number of Consideration
Shares that could be issued based on:
(i) the current market price ($0.012, being the latest closing price of Shares on
ASX prior to dispatch of this Notice);
(ii) twice the current market price ($0.024); and
(iii) half the current market price ($0.006).
Issue price Number of Consideration Shares to
be issued
$0.012 634,583
$0.024 317,292
$0.006 1,269,167
(d) The current total remuneration package for Mr Davis is $530,000 (inclusive of
superannuation). A$100,000 of this base salary will be paid after deducting any
amount required to be withheld on account of any tax payable in relation to the
issuance of shares (including any PAYG amount required to be withheld) via the
issue of Shares in equal quarterly instalments and within 120 days of the end of each
relevant quarter, subject to receipt of Shareholder approval.
(e) No Equity Securities have previously been issued under the Plan to Mr Davis.
(f) A summary of the material terms of the Plan is in Schedule 4.
(g) The value of the Consideration Shares to be issued will be $7,615.
(h) The Consideration Shares will be issued to Mr Davis (or his nominee/s) as soon as
practicable following the Meeting and, in any event, not later than 3 years after the
date of the Meeting.
(i) The Consideration Shares will be issued for nil cash consideration and are being
issued as part consideration for the provision of Services provided to the Company
pursuant to the Consultancy Agreement for the period January 2026 to March 2026.
Page 12
(j) No loan will be provided in relation to the issue of the Consideration Shares.
(k) Details of any Securities issued under the Plan will be published in the annual report
of the Company relating to the period in which they were issued, along with a
statement that approval for the issue was obtained under Listing Rule 10.14.
(l) Any additional persons covered by Listing Rule 10.14 who become entitled to
participate in an issue of Securities under the Plan after the Resolutions are approved
and who were not named in the Notice will not participate until approval is obtained
under Listing Rule 10.14.
(m) A voting exclusion statement is included in the Notice.
9.5 Chapter 2E of the Corp
Share your feedback
Discover